Dimensional Fund Advisors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-548
| Closed | -$27.5K | – | 3369 |
|
|
2024
Q2 | $27.5K | Sell |
548
-702
| -56% | -$35.3K | ﹤0.01% | 3341 |
|
|
2024
Q1 | $140K | Sell |
1,250
-2,817
| -69% | -$315K | ﹤0.01% | 3225 |
|
|
2023
Q4 | $236K | Sell |
4,067
-422
| -9% | -$24.5K | ﹤0.01% | 3168 |
|
|
2023
Q3 | $143K | Sell |
4,489
-3,095
| -41% | -$98.3K | ﹤0.01% | 3273 |
|
|
2023
Q2 | $624K | Sell |
7,584
-9,189
| -55% | -$756K | ﹤0.01% | 3016 |
|
|
2023
Q1 | $1.72M | Sell |
16,773
-2,818
| -14% | -$290K | ﹤0.01% | 2772 |
|
|
2022
Q4 | $2.87K | Sell |
19,591
-109
| -0.6% | -$16 | ﹤0.01% | 2618 |
|
|
2022
Q3 | $3.33M | Buy |
19,700
+11,338
| +136% | +$1.92M | ﹤0.01% | 2559 |
|
|
2022
Q2 | $965K | Buy |
8,362
+920
| +12% | +$106K | ﹤0.01% | 2924 |
|
|
2022
Q1 | $742K | Sell |
7,442
-339
| -4% | -$33.8K | ﹤0.01% | 3062 |
|
|
2021
Q4 | $1.21M | Buy |
7,781
+280
| +4% | +$43.5K | ﹤0.01% | 2980 |
|
|
2021
Q3 | $1.77M | Buy |
7,501
+461
| +7% | +$109K | ﹤0.01% | 2888 |
|
|
2021
Q2 | $2.39M | Sell |
7,040
-114
| -2% | -$38.7K | ﹤0.01% | 2822 |
|
|
2021
Q1 | $2.89M | Sell |
7,154
-128
| -2% | -$51.8K | ﹤0.01% | 2753 |
|
|
2020
Q4 | $4.84M | Sell |
7,282
-527
| -7% | -$351K | ﹤0.01% | 2542 |
|
|
2020
Q3 | $3.64M | Sell |
7,809
-155
| -2% | -$72.2K | ﹤0.01% | 2555 |
|
|
2020
Q2 | $4.66M | Sell |
7,964
-81
| -1% | -$47.4K | ﹤0.01% | 2500 |
|
|
2020
Q1 | $1.17M | Buy |
8,045
+4,026
| +100% | +$587K | ﹤0.01% | 2853 |
|
|
2019
Q4 | $576K | Buy |
4,019
+1,527
| +61% | +$219K | ﹤0.01% | 3114 |
|
|
2019
Q3 | $98K | Buy |
2,492
+1,155
| +86% | +$45.4K | ﹤0.01% | 3345 |
|
|
2019
Q2 | $135K | Buy |
+1,337
| New | +$135K | ﹤0.01% | 3364 |
|